Extract from the Register of European Patents

Citations: EP2558086

Cited inInternational search
Type:Patent literature
Publication No.:WO02098403  [X]
 (UNIV GEORGETOWN [US]; ANDREWS PETER [US]; DJAKIEW DANIEL [US]) [X] 1-8,10-14 * claims 1,3,8,10,13,15,20,22,26 *;
Type:Patent literature
Publication No.:WO8707842  [X]
 (BIOGEN NV [NL]; REICH STEVEN D [US]) [X] 1-4,6-8,10-14 * page 11, lines 3-7; figure 2; claims 7,9,19 *;
Type:Patent literature
Publication No.:KR20020026743  [X]
 ;
Type:Patent literature
Publication No.:WO0040271  [X]
 (ML LAB [GB]; DAVIES DONALD [GB]) [X] 1-8,10-14 * page 10, lines 25-30; claims 1,16-19,21 *;
Type:Patent literature
Publication No.:US6620834  [X]
 (TANIDA NORIFUMI [JP] ET AL) [X] 1-4,10-14 * column 2, lines 24-60; claims 1,2 *;
Type:Patent literature
Publication No.:WO2009140680  [X]
 (ALS MOUNTAIN LLC [US]; CHEN CHIEN-HUNG [US]) [X] 1-8,10-14 * paragraphs [0012] , [0013] , [0051] - [0054] - [0066] , [0075] , [0082] , [0087]; claims 1.3-7 *
Type:Non-patent literature
Publication information:[X]  - "Synergistic, anti-neoplastic composition for the treatment of cancerous tumors comprises arsenic and glutathione depleting compounds", DATABASE WPI, 0, Derwent World Patents Index, vol. 2002, no. 75, Database accession no. 2002-695782, XP002593977 & KR20020026743 A 20020412 (LEW YOUNG SUK [KR]; NEWGENPHARM CO LTD [KR]) [X] 1-8,10-14 * abstract *